Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1978639.
- Also identified by PMC identifier 1004237.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 56 year old woman with rheumatoid arthritis developed relapsing thrombocytopenia during successive treatments with aurothioglucose, sulphasalazine, and hydroxychloroquine. The presence of IgM or IgG antibodies or immune complexes reactive with autologous platelets could not be shown. Relapsing thrombocytopenia may indicate a genetically determined HLA-DR3 and B8 aberrant immunological response to stimuli such as certain second line drugs.
Medical subject headings
- Aurothioglucose
- Hydroxychloroquine
- Sulfasalazine
- Thrombocytopenia